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Abstract.  The capacity of human monocytoid cell 
lines and peripheral  blood monocytes to modulate 
their expression of plasminogen receptors has been as- 
sessed. After PMA stimulation,  THP-1  or U937 
monocytoid cells were separated into adherent and 
nonadherent populations.  Plasminogen bound to adher- 
ent cells with similar capacity and affinity as to non- 
stimulated cells.  In contrast,  the nonadherent cells 
bound plasminogen with 5-17-fold higher capacity 
(without a change in affinity).  This increase was selec- 
tive as urokinase bound with similar affinity and ca- 
pacity to the adherent  and nonadherent populations. 
Upregulation of plasminogen receptors on the nonad- 
herent monocytoid cells was rapid,  detectable within 
30 min,  and reversible,  adhesion of the nonadherent 
cells resulted in a  sixfold decrease in plasminogen 
binding  within 90 min.  The increase in plasminogen 
binding to the nonadherent cells was associated with a 
marked increase in their capacity to generate plasmin 
activity from cell-bound plasminogen. 
PMA stimulation of human peripheral  blood mono- 
cytes increased their expression of plasminogen recep- 
tors by two- to fourfold. This increase was observed 
in both adherent and nonadherent  monocytes. Freshly 
isolated monocytes maximally bound 5.0  x  1@ plas- 
minogen molecules per cell, whereas monocytes cul- 
tured for 18 h or more maximally bound 1.7  ×  107 
molecules per cell, a  30-fold difference in receptor 
number.  These results indicate that both monocytes 
and monocytoid cell lines can rapidly and markedly 
regulate their expression of plasminogen binding  sites. 
As enhanced plasminogen binding  is correlated with 
an increased capacity to generate plasmin,  an enzyme 
with broad substrate recognition,  modulation of plas- 
minogen receptors may have profound functional con- 
sequences. 
C 
ELL-ASSOCIATED proteases participate  in a wide va- 
riety of physiological and pathophysiologic processes. 
The enzymes of the fibrinolytic system, the plasmino- 
gen activators (urokinase  [u-PA] 1 and tissue plasminogen ac- 
tivator  [t-PA]), and plasmin,  together represent  one of the 
most broadly distributed  and utilized of these protease  sys- 
tems. Plasmin is a serine protease with broad substrate recog- 
nition (49). In addition to its role as the primary enzyme in- 
volved in dissolution of fibrin deposits, plasmin also degrades 
a number of matrix proteins (41). This capability suggests that 
cell-associated plasmin also may play a key role in regulating 
cell migration. 
Cell  surface receptors  for plasmin,  its  zymogen,  plas- 
minogen,  and  for  the  plasminogen  activators  provide  a 
mechanism for cells to harness  and regulate the activities of 
these proteases for performance of cellular functions. Cellu- 
lar binding sites for plasminogen  (36, 45), plasmin (8), u-PA 
(1, 6,  12, 57), and t-PA (2,  3,  19) have been demonstrated 
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on a  variety of cells,  and  evidence for the  regulation  of 
specific  cellular responses by these receptors is  evolving. 
Plasmin(ogen)  receptors are particularly widely distributed 
[reviewed in reference 36] and play a key role in regulating 
the activity of plasmin  at cell surfaces. 
Monocytes/macrophages exhibit a complex interrelation- 
ship with the fibrinolytic  system. These cells can synthesize 
both u-PA (56) and t-PA (21, 22) as well as inhibitors of plas- 
minogen  activators  (10). The biosynthesis of these fibrino- 
lytic components can be modulated by agonists (21, 22, 30, 
58, 63). In addition,  monocytes and monocytoid cell lines 
express both u-PA and plasminogen  receptors (35, 45, 57). 
Direct evidence for the occupancy of plasminogen  receptors 
on  macrophages  within  inflammatory  regions  has  been 
demonstrated recently (51). In addition,  monocytoid cells 
have the capacity to modulate their expression of u-PA recep- 
tors in response to agonists  (14, 26, 29, 44, 52, and Lu et 
al.  1989. Thromb. Haemostasis.  62:91).  Thus,  monocytoid 
cells possess numerous distinct  mechanisms for regulating 
the proteolytic activity of the fibrinolytic system. In this study, 
we have investigated whether human monocytes and mono- 
cytoid cell lines can modulate their expression of plasmino- 
gen receptors. In view of the importance of the migratory 
functions of these cells in inflammatory processes and their 
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modulation of their plasminogen receptor function would be 
of central importance. Specific conditions are now identified 
which result in marked differences in plasminogen receptor 
expression, and these differences are associated with dramatic 
changes in the fibrinolytic activity of these cells. 
Materials and Methods 
Proteins 
Glu-plasminogen was  isolated  from fresh plasma (prepared from blood 
drawn into 50 t~g/ml soybean trypsin inhibitor [Sigma Chemical Co., St. 
Louis, MO],  100 kallikrein inhibitor units/ml trasylol [FBA Pharmaceuti- 
cals, New York,  NY], 3 mM benzamidine and 3 mM EDTA), by affinity 
chromatography on lysine-Sepharose (13) (Pharmacia Fine Chemicals, Pis- 
cataway,  NJ) in the presence of 1 mM benzamidine, 0.02%  NAN3, and 3 
mM EDTA.  The protein concentration was determined spectrophotometri- 
cally at 280 nm using an extinction coefficient  of 16.8 (60). Lys-plasminogen 
was purchased from National Institute for Biological Standards and Control 
(London,  England).  High-molecular weight two-chain urokinase  (u-PA) 
was  purchased  from  Calbiochem-Behring Corp.  (La  Jolla,  CA).  Glu- 
plasminogen and u-PA were radiolabeled using a  modified chloramine T 
method (45). After labeling, u-PA was routinely repurified by affinity chro- 
matography on benzamidine-Sepharose (24) and subsequently inactivated 
by treatment with 5 mM diisopropyl fluorophosphate for 30 min at 4°C. The 
labeled and unlabeled preparations of the ligands used in this study had the 
characteristics of previously described preparations from our laboratory 
(3Z 45). 
Cells 
The human monocytoid THP-1  cell line (55)  was cultured in RPMI-1640 
containing 100 U/ml penicillin G, 100/~g/ml streptomycin, 1 mM Na pyru- 
vate, 0.05 M Hepes pH 7.35, 5  x  10-4% 2-mercaptoethanol, and 5% FCS 
(Mo-Medium). The human monocytoid cell line U937 and the human my- 
eloid cell line HL60 were grown in RPMI-1640 containing 100 U/ml peni- 
cillin G,  100/~g/ml streptomycin and 5%  FCS. 
Human peripheral blood monocytes were prepared from blood drawn into 
5  U/ml heparin,  10 mM theophylline, and  10 /~g/ml prostaglandin El~,. 
The  blood  was  immediately centrifuged at  500  g  for  10  min,  and the 
platelet-rich plasma removed. After platelet depletion, two different pro- 
tocols were used  for monocyte isolation.  Monocytes, isolated using an 
adhesion step,  were prepared by  centrifugation of the  platelet-depleted 
blood cells, resuspended to the original blood volume in RPMI-1640, onto 
Ficoll-Hypaque (8%  Ficoll [Sigma Chemical Co.],  10%  Hypaque [Win- 
throp-Breon, New York, NY], d  =  1.3570) to obtain the mononuclear cell 
fraction, and subsequent adherence of these cells (40-100  x  106 cells in 
10-15 rnl RPMI-1640 medium) on fibronectin-gelatin dishes (5, 25) under 
sterile conditions. Fibronectin-gelatin dishes were prepared by incubation 
of 2% gelatin (type II; Sigma Chemical Co.) (10 ml/dish) for 1 h at 37°C, 
washing three times with Dulbecco's PBS (DPBS) and addition of autolo- 
gous heparinized platelet-poor plasma (10 ml per dish). After 30 rain at 
22°C and 1 h at 4°C, the plates were washed three times with DPBS and 
immediately used for adhesion of monocytes. After 1 h of adherence at 
22°C, nonattached cells were removed by washing, and adherent monocytes 
were removed by incubation with 3.5 mM EDTA in DPBS for 10 rain at 4°C. 
Isolation of monocytes without adhesion was performed using Seph- 
racell-MN (Sephractec Co., Oklahoma City, OK) as described (59). Briefly, 
Sephracell-MN was added to the platelet-depleted cell pellet at a ratio of 
0.6:1 (vol/vol). After mixing by inversion, the suspension was centrifuged 
for 20 rain at  1,500  g. The mononuclear cell fraction was removed from 
the upper phase of the Sephracell-MN and washed once in PBS containing 
0.1% BSA (Calbiochem-Behring Corp.) (PBS  +  BSA). Pellets of mono- 
nuclear cells were resuspended in PBS  +  BSA, mixed again with Seph- 
racell-MN at a ratio of 1:2 (volume/volume), and centrifuged for 20 min 
at 1,500 g. After washing once in PBS +  BSA, monocytes were suspended 
in Mo-medium. 
Purity of the monocyte preparations was determined by microscopic ex- 
amination of cells after Giemsa (Harleco,  Gibbstown,  N J)  and esterase 
staining (15). In addition, preparations were subjected to FACS analysis (see 
below)  using  an  mAb  against  the  Mac-1  alpha  chain  (MI/70)  (kindly 
provided by Dr. D. Altieri from the Research Institute of Scripps Clinic, La 
Jolla,  CA)  (4).  Only monocyte preparations containing <20%  platelets 
(mean 13  +  4%  in 6 experiments) and <10%  lymphocytes were used in 
this study. (At a 20% contamination level, platelets would account for <1% 
of the 125I-plasminogen binding observed with a monocyte preparation). In 
addition monocyte preparations were routinely assayed for procoagulant ac- 
tivity (PCA) as an index for the absence of stimulation with LPS or other 
agonists (28), and only preparations expressing <30 mU/106 cells were used. 
Cell Stimulation and Adhesion 
12-O-Tetradecanoylphorbol-13-acetate (PMA) (Sigma Chemical Co.), was 
routinely added at 40  nM to monocytoid cells and 4  nM to monocytes 
(monocytes were stimulated at a  10-fold lower concentration to minimize 
cytotoxicity). Unless indicated, stimulation was performed for 18 h in Mo- 
medium under sterile conditions. Viability was assessed by trypan blue ex- 
clusion and recovery by counting of cells in a hemocytometer. After PMA 
stimulation monocytoid cells become more adherent (54) and the propor- 
tion of adherent cells depends on the surface provided. At selected times, 
nonadherent cells were recovered by gentle decanting and the adherent cells 
by flushing with a pipette. Several types of vessels were used to obtain vary- 
ing proportions of adherent and nonadherent cells. Using THP-1 cells, the 
following percent adherence was obtained after treatment with PMA (40 
nM) for  18 h:  150-cm 2 flasks (Costar, Cambridge, MA), 60-75%;  100- 
ram dishes (Corning Glass Works, Coming, NY), 55-75 % (5-10 % without 
PMA  stimulation);  30  ml  Teflon  bottles  (Nalge  Co.,  Rochester,  NY), 
15-25%  (3-5%  without  PMA  stimulation);  gelatin-fibronectin  dishes 
(85-95 %). Unless otherwise indicated, the 100-mrn Corning dishes were 
used in all  experiments with the monocytoid cell lines. 
Ligand Binding Analyses 
Before use in binding analyses, the cells were washed three times in HBSS 
containing 1.2 mM CaCl2 and 1.6 mM MgSO4 (HBSS) and resuspended in 
HBSS containing 0.05 M Hepes, pH 7.35, and 0.1% BSA (HBSS-Hepes). 
Binding analyses were carried out in 1.5 ml polypropylene snap-cap tubes. 
Radiolabeled ligands, typically 100 nM 125I-plasminogen and 1 nM 1251-u- 
PA (final concentrations), unlabeled ligands, or buffer were added to a final 
volume of 200/zl. The cells were at 1.0 ×  106 or 1.5  ×  107 cells/ml in this 
200-#1  volume for measuring plasminogen or u-PA binding, respectively. 
After incubation at 37°C for 1 h, triplicate 50-~1 samples were layered over 
300 #1 20% sucrose in HBSS-Hepes and centrifuged for 2.5 rain in a Beck- 
man microfuge (Beckman Instruments, Inc., Fullerton, CA). The tube tips 
were cut off and counted in a gamma counter. Molecules of ligand bound 
per  cell  were  calculated  based on the  specific activity  of each  ligand. 
Specific binding was measured as the difference in the radioactivity bound 
to the cells in the presence and absence of a 40-100-fold final molar excess 
of nonlabeled ligand.  Dissociation constants (Kd) were determined from 
specific binding isotherms using a  nonlinear curve-fitting computer pro- 
gram, Ligand (42).  Linear correlation coefficients were calculated with a 
TI-55-II calculator (Texas Instruments Inc., Dallas, TX).  Statistical com- 
parisons were done using a paired comparison t test. 
In some experiments, the cells were treated at low pH to remove potential 
endogenous ligands bound to receptors. The conditions under which >80% 
of t251-plasminogen or 125I-u-PA bound to the cells was dissociated were 
established for each cell type. These conditions were 10 min at pH 3.5 or 
pH 4.0 for the cell lines or monocytes, respectively. After this treatment the 
cell lines were >85-90% viable and monocytes were 65-70% viable. After 
such treatments, each cell type retained >90% of its capacity to bind added 
~25I-plasminogen or ~25I-u-PA. 
SDS-PAGE 
Cell-bound ligands were extracted with 0.1% Triton-X-100 in 0.1 M Tris, 
pH 8.1, containing 10 mM EDTA, 1 mM PMSF, 100 U/ml trasylol. Extracts 
were boiled for 5 min and electrophoresed  under reducing conditions on 8 % 
polyacrylamide slab gels in the buffer system of Laemmli (27).  Gels were 
stained with Coomassie blue, dried, and autoradiograms were developed 
with XRP-1  film (Eastman Kodak, Rochester, NY).  The autoradiograms 
were scanned using a soft laser densitometer (Zeineh; Biomed Instruments 
Inc., Fullerton, CA). Molecular weights were estimated relative to protein 
standards obtained from Amersham Corp. (Arlington Heights, IL). Rela- 
tive mobility (Rm) was calculated by dividing the distance from the top of 
the gel to the leading front of a protein band by the distance from the top 
of the gel to the dye front (61). 
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Cells (1.0 x 106) were lysed in 1 ml of 0.1% Triton-X-100 in 0.1 M Tris, pH 
8.1, containing 10 mM EDTA,  1.0 mM PMSE  100 U/rnl trasylol. The ex- 
tract, 20 #1, was applied to Immobilon-P filter paper (Millipore Co., Bed- 
ford,  MA), using a  dot-blot apparatus (Bethesda Research Laboratories, 
Gaithersburg,  MD).  After 90  min at  37°C,  the filters  were extensively 
washed with PBS containing 2 % BSA and incubated with 1251-plasminogen 
(100 nM) in the same buffer for 1 h at 37°C on a shaker. After washing with 
2% BSA in PBS for 1 h with several changes, the filters were air dried and 
subjected to autoradiography. 
Cell-associated Fibrinolytic Activity 
Plasmin generation by isolated cell populations was determined after prein- 
cubating the cells (1.5 x  106/rnl in HBSS) with 15/xM Glu-plasminogen for 
1 h at 37°C and washing the cells twice with HBSS. Plasmin generation was 
measured at 405 nm as a  function of time after addition of u-PA (3 nM) 
and the chromogenic substrate S-2251  (0.5 mM) (Kabi Vitrum, Malta6, 
Sweden), in Tris HC1 pH 8.8, in a final volume of 200 tzl, using an ELISA 
plate reader (Molecular Devices, Palo Alto, CA). 
FACS Analysis of  Monocyte Preparations 
Fluorescein-conjugated plasminogen (FITC-plasminogen) was prepared by 
conjugation of Glu-plasminogen with fluorescein (Sigma Chemical Co.) as 
described (16).  Conjugated fluorescein was separated from free fluorescein 
on Sephadex G-25 in PBS containing 0.1%  NAN3. The fluorescein/protein 
ratio ranged from two to four (53). To characterize the conjugate, its capac- 
ity to inhibit plasminogen binding to cells was assessed. 1251-plasminogen 
(0.1  ~M) binding to THP-1 cells was 80% inhibited by 2 pM unlabeled plas- 
minogen and 74%  inhibited by 2/~M FITC-plasminogen. For binding of 
FITC-plasminogen to monocytes and subsequent FACS analysis, ceils (1 x 
107/ml)  were incubated with FITC-plasminogen (10 ~M) in HBSS-Hepes 
containing 0.1% BSA for 1 h at 37°C. After washing once, the resuspended 
cells were analyzed by flow cytometry in a Becton Dickinson FACS IV/40 
(Becton Dickinson Co., Oxnard, CA). Purity of the monocytes was assessed 
by incubation with a saturating concentration of MI/70 antibody followed 
by fluorescein-conjugated goat F(ab')  2 anti-mouse IgG (reactive with heavy 
and light chains) (Tago Corp.,  Burlingame, CA),  and subsequent FACS 
analysis. 
Results 
Expression of  Fibrinolytic Receptors on THP-1 Cells 
The U937  cell line has been used extensively to study the 
fibrinolytic properties  and  the  interactions  of monocytoid 
cells with fibrinolytic molecules (30, 44, 45, 52, 57). THP-1 
cells exhibit a number of the characteristics of monocytes in- 
cluding ones not expressed by U937 cells (55) such as major 
histocompatibility class-II antigens (64). Therefore, we sought 
to determine whether THP-1 cells could serve as a second 
model monocytoid cell line by studying the binding of the 
fibrinolytic ligands, plasminogen and u-PA, to the cells. In 
initial experiments, we found that both ~25I-plasminogen and 
125I-u-PA bound to THP-1 cells in a time dependent manner. 
At 37°C,  apparent equilibrium was achieved at 60 and 30 
min for plasminogen and u-PA, respectively, typical of the 
time courses for binding of these ligands to monocytes, U937 
cells,  and many other cell types (36,  45).  Binding  of both 
ligands was saturable.  At a  100-nM  input concentration of 
~25I-plasminogen,  binding  was  83 %  inhibited by a  40-fold 
molar excess of nonlabeled plasminogen (eight experiments). 
With  t25I-u-PA at a  1 nM input concentration, binding was 
86 % inhibited by a 50-fold molar excess of nonlabeled u-PA 
(six experiments). The reversibility ofplasminogen and u-PA 
to the THP-1 cells was assessed. Radiolabeled plasminogen 
(100 nM) or u-PA (1  nM) was incubated with the cells for 
1 h at 37°C. At this time, a 90-fold excess of the homologous 
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Figure 1. Scatchard plots for the binding of plasminogen (A) and 
urokinase (B) to THP-1 cells. Data are derived from specific bind- 
ing isotherms  for the two ligands. The plasminogen binding  iso- 
therm was constructed  by adding varying amounts of nonlabeled 
plasminogen (0.1-10 #M) and a constant amount of ~2SI-plasmino- 
gen (100 nM) to cells. The plasminogen binding parameters derived 
are: Kd =  1.8/~M with 2.4  ×  l07 total binding sites per cell. u-PA 
binding isotherms (B) were constructed by adding varying amounts 
of tzSI-u-PA  to the cells (3.75  x  106/ml). Incubations were for 60 
min at 37°C. The urokinase binding parameters derived are: Kd = 
1.3 nM with 7.6  ×  104 total binding sites. 
nonlabeled ligand was added, and the extent of ligand bind- 
ing was measured after an additional  10 or 30 min. Relative 
to the ~2~I-plasminogen specifically bound to the cells at 60 
min,  the excess nonlabeled plasminogen displaced 70 and 
81% of the bound ligand within 10 and 30 min, respectively. 
Similar results were obtained with u-Pa; the excess nonla- 
beled u-PA displaced 67 and 71%  of the bound ~25I-u-PA af- 
Table L Binding of  Plasminogen 
and Urokinase to Nonstimulated and the Adherent 
and Nonadherent Populations of  PMA-stimulated 
Monocytoid Cell Lines 
Plasminogen binding (molecules per cell  x  10  6) 
PMA-stimulated 
Cell type  Nonstimulated  Adherent  Nonadherent 
U937  0.4  +  0.1  0.3  +  0.1  1.7  +  0.1 
THP-1  0.3  +  0.1  0.3  +  0.1  1.9  +  0.1 
HL-60  0.5  +  0.2  0.2  +  0.1  1.1  _  0.1 
Urokinase binding (molecules per cell  ×  10  4) 
Cell type  Nonstimulated  Adherent  Nonadherent 
U937  1.8  -t- 0.3  3.2  +  0.6  3.9  +  0.5 
THP-I  2.1  +  0.1  4.1  +  1.9  5.3  +  3.4 
HL-60  1.3  +  0.3  0.6  +  0.3  1.2  +  0.2 
Specific binding (binding inhibitable  by excess nonlabeled ligand) of plasmino- 
gen and urokinase were measured with the radiolabeled  ligands at 100 and 1 
nM, respectively, after a 60-min incubation at 37 °C, PMA (40 nM) stimulation 
was for 18 h, and the adherent and nonadherent cell populations were separat- 
ed. The means +SD from three to six experiments are indicated. 
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the reversibility of the binding of these ligands to U937 cells 
reported by us (45) and others (51).  Representative Scatch- 
ard plots for the binding of plasminogen and  u-PA  to the 
THP-1 cells are shown in Fig.  1. The data points from each 
Scatchard plot fit a straight line; the linear correlation coeffi- 
cients for plasminogen and u-PA were r =  -0.98 and -0.97, 
respectively. Scatchard analyses of the data from several ex- 
periments gave an average Kd of 1.8  +  0.5  #M and 2.4  + 
3.0  ×  107 plasminogen molecules maximally bound per cell 
(eight experiments). For u-PA, the Kd value was  1.3  +  1.0 
nM and 7.6  5-  2.7  ×  1@ u-PA molecules were maximally 
bound per cell (six experiments). These values are very simi- 
lar to those we have obtained for the binding of these two 
fibrinolytic ligands to U937 cells (45). 
Modulation  of  Plasminogen Receptors 
on Monocytoid Cells 
Expression of u-PA receptors on U937 cells is increased by 
treatment with PMA, and this change has been reported to 
be more evident in the population of cells which become ad- 
herent after PMA stimulation (44, 52). We sought to deter- 
mine whether PMA, an agonist that exerts diverse effects on 
monocytes and monocytoid cells, could differentially modu- 
late plasminogen receptor expression in the adherent and 
nonadherent populations of THP-I and U937 cells.  THP-1 
and U937 cells were cultured for 18 h in either the presence 
or absence of 40 nM PMA.  The nonadherent and adherent 
cells were recovered separately, and  ~:5I-plasminogen bind- 
ing to the two populations of each cell type was measured. 
At an input ligand concentration of 100 nM, marked differ- 
ences in plasminogen binding to the two populations of cells 
were observed (Table I). Whereas the adherent population of 
PMA-stimulated cells bound similar levels of plasminogen 
as the nonstimulated cells, binding to the nonadherent cells 
was greatly enhanced. The nonadherent THP-1 cells and U937 
cells bound sixfotd more plasminogen compared to the ad- 
herent  populations.  Such  differences were  also  observed 
with a third cell line that acquires macrophage characteris- 
tics upon PMA stimulation, the human promyeloid leukemic 
HL60 cell line. The nonadherent population of HL60 cells 
bound  five times more ~25I-plasminogen than the adherent 
HL60 cells (Table I).  In contrast to these marked changes 
in plasminogen binding, u-PA binding was less dramatically 
altered. PMA stimulation increased u-PA binding by two- to 
threefold,  and  the  adherent  and  nonadherent  THP-1  and 
U937 cells showed no significant differences in binding (P 
>  0.05)  based upon a paired comparison t-test. 
To determine whether the observed differences in plas- 
minogen receptor expression reflected an altered affinity or 
capacity of the cells for the ligand, Scatchard analyses were 
performed with separated adherent and nonadherent popula- 
tions  of PMA-stimulated  THP-1  and  U937  cells.  Straight 
lines were obtained suggesting that the differences were not 
due to induction of a second class of receptors with respect 
to affinity.  The binding parameters summarized in Table II 
indicate that the affinity of plasminogen for the adherent and 
nonadherent PMA-stimulated  cells  and  for the  nonstimu- 
lated cells was  very similar.  The number of binding sites, 
however, increased markedly in the nonadherent cells. The 
difference between the adherent and nonadherent cells was 
17-fold with the THP-1 cells and 5-fold with the U937 cells. 
Table II. Summary of  the Binding Parameters  for 
the Interaction of  Plasminogen and Urokinase with 
Nonstimulated and the Adherent and Nonadherent 
Populations of  PMA-stimulated Monocytoid Cells 
Plasminogen binding 
THP-1  cells 
PMA-stimulated 
Binding parameter  Nonstimulated  Adherent  Nonadherent 
Kd (,uM)  2.1  5- 0.4  2.7  +  2.4  3.5  +  3.0 
Sites (x  107)  1,2  5- 0.3  1.0  5- 0.6  16.9  +  0,8 
U937 cells 
Kd (,aM)  1.2  +  0.2  2.0  5- 0.1  2.2  5- 0.4 
Sites (x  107)  3.2  5- 0.8  1.9  5- 0.2  10.2  5-  3.0 
Urokinase binding 
THP-1  cells 
PMA-stimulated 
Binding parameter  Nonstimulated  Adherent  Nonadberent 
Ka (nM)  1.3  5-  1.0  1.0  5- 0.7  1.0  +  0.9 
Sites (x  104 )  7.6  5- 2.7  13.8  5-  1.5  14.9  5-  1.3 
U937 cells 
Kd (nM)  0.7  +  0,3  1.2  5-  1.0  1.1  +  1.2 
Sites (x  104 )  2.3  +  1.5  6.0  5- 4.0  5.3  +  4.8 
The binding parameters are derived from nonlinear curve-fitting analyses in the 
ligand computer program of specific binding isotherms for the two ligands to 
the monocytoid cells. The results are the means +SD from four to six ex- 
periments, 
To assure ourselves that such large differences in number of 
plasminogen binding sites on the adherent and nonadherent 
cells could be accurately quantitated in the assay configura- 
tion used,  we measured the plasminogen binding at final 
nonstimulated  THP-1  cell concentrations of 5.6  ×  106/ml 
and 0.5  ×  106/ml.  This  ll-fold difference in cell number 
approximates the difference in the plasminogen binding ca- 
pacity of the adherent and nonadherent cells. At a  100 nM 
~25I-plasminogen input concentration, 4.4  -J- 0.4  ×  105 and 
3.0  +  1.19 ×  105 plasminogen molecules were bound per 
cell  (mean  +SD  of three experiments) at  the higher and 
lower input concentration, respectively. As these differences 
are not statistically significant (P >  0.05), the 5- to 17-fold 
differences in the binding capacity of the nonadherent and 
adherent  monocytoid cells  appear  to be appropriate esti- 
mates. 
The changes in u-PA binding in these same cell popula- 
tions were more modest and also arose from an increase in 
the  number of binding  sites  and  not from an  increase in 
affinity. The differences in u-PA binding to the adherent and 
nonadherent populations of PMA-stimulated ceils were not 
statistically significant (P > 0.05), for either the U937 or the 
THP-1  cells. Stimulation of the two cell lines for up to 5 d 
with 120 nM PMA failed to induce greater changes in u-PA 
receptor expression.  Acidification to remove any receptor 
associated endogenous u-PA did not enhance the capacity of 
the stimulated adherent or nonadherent cells to bind u-PA. 
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of plasminogen  binding to non- 
stimulated and the adherent and 
nonadherent populations of PMA- 
stimulated THP-1 cells. Twofold 
dilutions of detergent extracts of 
the indicated populations of 1.0 x 
106 THP-1 cells/ml  were dotted 
onto Immobilon-P filters and then 
reacted  ~2SI-plasminogen (100 
nM). The blots were then washed 
after 90 rain at 37°C, and auto- 
radiograms developed. 
For example, acid-treated, nonadherent THP-1 cells bound 
6.2  5:1.5  x  104 molecules/cell compared with 5.3  +  3.4 
×  1@ molecules/cell for the non-acid-treated cells (1  nM 
~25I-u-PA added).  Acidification  also  did  not  enhance  the 
binding capacity of the cells for ~25I-plasminogen, suggest- 
ing that the plasminogen binding sites were not occupied by 
endogenous ligands. 
The effect of varying doses of PMA on the upregulation 
of plasminogen receptors in the nonadherent cells was ex- 
plored. With a  100-nM input concentration of ~25I-plasmin- 
ogen, the ratio of plasminogen molecules bound to the non- 
adherent and adherent ceils ranged from 9:1  to 5:1  using 
doses of PMA in the 10-120-nM range. Lower PMA doses 
(2-6 nM) induced variable responses. As an independent in- 
dex of the response of the cells to PMA, the procoagulant 
activity (PCA) of the cell lysates was measured.  After an 
18-h exposure to 40 nM PMA, U937 cells expressed 4,000 
mU/106 cells compared with 350 mU/106 cells in the nonstim- 
ulated U937 cells. The procoagulant activity (PCA) response 
in the THP-1 ceils reached a  maximum at an earlier time 
point.  At 5  h,  the PMA stimulated THP-1 cells expressed 
5,000 mU/106 cells compared with 300 mU/106 nonstimu- 
fated cells. These data are in agreement with published re- 
ports (17, 47) on the PCA of these monocytoid cell lines after 
PMA stimulation. 
The enhanced binding of plasminogen to the nonadherent 
cells  was  also  demonstrable  in  ligand  dot-blot  analyses. 
Serial dilutions of detergent extracts of the same number of 
adherent and  nonadherent PMA stimulated and nonstimu- 
lated THP-1 cells were applied to an Immobilon filter. After 
thorough washing,  the  filter was  incubated  with  t2SI-plas- 
minogen and then thoroughly washed again.  An autoradio- 
gram of the filter is  shown in  Fig.  2.  Reactivity with the 
t25I-plasminogen  is clearly observed at higher dilutions of 
the nonadherent cells than of the adherent or the nonstimu- 
lated cells. All binding to the filter was abrogated (reviewed 
in reference 36) by 0.2 M  6-AHA (not shown), which pre- 
vents plasminogen binding to cells. Thus, this ligand dot-blot 
system provides a  facile means to detect and compare the 
plasminogen binding capacity of cells and corroborates the 
increase in plasminogen binding to the nonadherent THP-1 
cells. 
Plasmin has been reported to bind to cells with a higher 
affinity than plasminogen (8). To determine whether differ- 
ential activation of plasminogen to plasmin could account for 
the differences in ligand binding, the ligands bound to the ad- 
herent and nonadherent ceils were analyzed on SDS-PAGE 
gels.  Under reducing conditions, plasminogen (Mr =  92,000) 
can be distinguished from the plasmin heavy chain (Mr  = 
62,000).  Autoradiograms of the gels were developed and 
then analyzed by densitometric scanning. At 1 h, the radiola- 
beled ligand incubated in the absence of cells was 93 % plas- 
minogen and 7 % plasmin. The ligand bound to nonadherent 
and adherent cells as 83 and 81% plasminogen, respectively. 
Thus, the cells caused a moderate conversion of  plasminogen 
to plasmin, but no difference in the amount of plasmin bound 
to the stimulated nonadherent and adherent cells was noted. 
Moreover, the extent of plasmin formation was similar in the 
bound and unbound ligand. This modest conversion of plas- 
minogen to plasmin by the cells (10-12%) is in agreement 
with previous published data (19, 45, 51) and with other ob- 
servations suggesting a  similar affinity of plasminogen and 
plasmin for cells (20,  34, 39). To exclude that the traces of 
plasmin generated by cells could give rise to the differences 
in  plasminogen binding  to  the  adherent and  nonadherent 
monocytoid cells, THP-1 cells were stimulated with PMA 
(40 nM) for 90 min, and plasminogen binding to the nonad- 
herent and adherent cells determined in the presence or ab- 
sence of 100 U/ml trasylol. At a 100-nM input concentration 
of t25I-plasminogen,  the nonadherent cells bound 6.3- and 
5.3-fold more molecules of plasminogen per cell than the ad- 
herent cells, in the presence or absence of trasylol, respec- 
tively. 
It  also  has  been  reported  that  Lys-plasminogen has  a 
higher affinity for cells than native Glu-plasminogen (18, 38, 
Figure 3. Molecular identity ofplasmin- 
ogen  bound  to  THP-1 cells. 125I-glu- 
plasminogen (100 nM input concentra- 
tion) was incubated with adherent and 
nonadherent  PMA-stimulated  THP-1 
cells (1.5 ×  106/ml)  for 1 h at 37°C and 
the bound ligand was extracted using a 
0.1%  Triton  solution  as  described  in 
Materials and Methods. Cell bound ma- 
terial as well as ligand added (~25I-Glu- 
plasminogen  or  ~25I-Lys-plasminogen) 
were analyzed by SDS-PAGE  using 8% 
polyacrylamide gels under nonreducing 
conditions. In the autoradiogram shown, 
lane  1  is the  added Glu-plasminogen; 
lane 2 is Lys-plasminogen; and lanes 3 
and 4 are the ligands bound to the nonad- 
herent and adherent cells, respectively. 
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Adherent and Nonadherent Populations of  PMA-stimulated 
and Nonstimulated THP-1 Cells 
Plasminogen (molecules  Urokinase (molecules 
x  106/cell)  x  104/cell) 
Ceil  PMA-  PMA- 
population  Nonstimulated  stimulated  Nonstimulated  stimulated 
Adherent 
ceils  0.2  +  0.1  0.3  +  0.2  3.4  +  0.1  4.2  +  0.3 
Nonadherent 
cells  0.3  -I- 0.1  4.2  +  0.3  3.3  5:0.4  5.3  +  0.3 
Gelatin-fibronectin was used to separate an adherent and a nonadherent popula- 
tion of nonstimulated THP-1 cells and of cells stimulated with 40 nM PMA for 
18 h. The specific binding of plasminogen and u-PA was measured with the 
radiolabeled ligands at 100 and 1 nM concentrations,  respectively. The means 
+SD from three experiments,  are  indicated. 
51).  To determine whether the increase in ligand binding to 
the nonadherent cells was due to this alteration, SDS-PAGE 
analyses were performed on the cell-bound ligands  under 
nonreducing conditions under which Glu and Lys-plasmin- 
ogen are distinguished. An autoradiogram of the gel is shown 
in Fig. 3. After 1 h of binding to the cells, the material bound 
to the nonadherent and adherent cells had similar mobilities 
and remained predominantly Glu-plasminogen (Rm =  0.33 
for both cell types). Thus, the ligands bound to the adherent 
and nonadherent cells were indistinguishable.  (The mobili- 
ties of the bound ligands were similar to but not precisely 
identical  to isolated Glu-plasminogen [Rm =  0.32]  and clearly 
distinct from the Lys-plasminogen standard  [Rm =  0.37]). 
Requirements for the Modulation  of Plasminogen 
Receptor Expression on Monocytoid Cells 
The relationship between PMA stimulation and cell adhe- 
sion  in regulating plasminogen receptor expression in the 
monocytoid cells was examined. Nonstimulated THP-1 cells 
can adhere to fibronectin-gelatin;  and this substratum was 
used to separate an adherent and a nonadherent population 
of nonstimulated as well as of PMA-stimulated cells. When 
~25I-plasminogen binding was measured, the stimulated and 
nonstimulated  adherent  cells  bound  similar  levels  of the 
ligand (Table III). In contrast,  plasminogen binding to the 
two  nonadherent  cell  populations  differed  markedly.  The 
nonstimulated,  nonadherent  cells  showed  no  significant 
difference in plasminogen binding compared with the adher- 
ent nonstimulated cells.  The stimulated nonadherent cells, 
however, bound 14 times more plasminogen compared to the 
stimulated  adherent  population.  Thus,  stimulation  of the 
cells was necessary for augmented plasminogen binding to 
the  nonadherent  cell  population,  u-PA  binding  increased 
slightly, but not significantly, in both the adherent and nonad- 
herent populations of stimulated cells. 
To  determine  the  role  of cell  adhesion  in  plasminogen 
receptor  modulation,  THP-1  cells  were  stimulated  with 
PMA in tissue culture flasks which allow only minimal cell 
adhesion.  Under conditions where <0.1% of the cells were 
adherent after 18 h of stimulation with PMA, no increase in 
plasminogen binding to the cells was observed (2.8  +  1.2 
and  3.1  +  0.8  x  105 molecules bound per cell for stimu- 
lated and nonstimulated cells respectively, at an input con- 
centration  of  100  nM  ~:5I-plasminogen).  This  result  sug- 
gests  that  an  adherent population  of cells  is  required  for 
modulation of plasminogen receptor expression in the non- 
adherent  cells,  and  this  possibility  was  further  assessed. 
THP-1 cells were stimulated with PMA in vessels with vary- 
ing surface areas and adhesive properties such that the ratio 
of adherent to nonadherent cells differed. Plasminogen bind- 
ing to the adherent and nonadherent populations was then 
measured. As shown in Fig. 4, under conditions where <40 % 
of the  cells  were adherent,  no  difference  in  plasminogen 
binding to the adherent and nonadherent populations was de- 
tected. When the population of adherent cells exceeded 60%, 
the nonadherent cells exhibited more extensive binding of 
plasminogen compared to the adherent population. 2 Thus, 
to upregulate plasminogen receptor expression in the nonad- 
herent cells, a significant proportion of the cells had to be- 
come adherent. These data also imply that the extent of sur- 
face available for adherence and not the presence of a distinct 
subpopulation of nonadherent cells is responsible for the sepa- 
ration of the two populations of cells and the modulation of 
receptor expression in the nonadherent cells. Corroboration 
of this point was obtained by exposing an isolated population 
of stimulated nonadherent cells to a second culture flask and 
again separating adherent and nonadherent populations (Ta- 
ble IV). The nonadherent cell population became 78 % ad- 
herent after 90 min in a new culture dish. Adherence induced 
downregulation of receptors in the previously nonadherent 
population and the new population of nonadherent cells bound 
eightfold  more plasminogen  molecules  than  the  adherent 
cells.  This eightfold difference was observed in either the 
presence or absence of PMA added during the second ad- 
herence. 
2.  As noted  in Materials  and  Methods,  some variation  was observed  in the 
distribution  of adherent  and  nonadherent  cells  under similar  experimental 
conditions.  This difference in distribution  could account for the variability in 
the increment in plasminogen binding to the nonadherent  versus the adherent 
cells. In the experiments  with THP-1 cells reported  in the study, the ratio of 
plasminogen binding to the nonadherent versus the adherent cells ranged from 
5.8 to 16.9, a 2.9-fold  variation. 
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Figure 4.  Influence of cell adhesion on plasminogen receptor ex- 
pression.  THP-1 cells were stimulated with 40 nM PMA for 18 h 
in different culture vessels to allow varying proportions of adherent 
and nonadherent populations to develop. (Ratio) Number of 1251- 
plasminogen (at a 100-nM input concentration) molecules specifi- 
cally bound to nonadherent cells divided by the number of mole- 
cules bound to the adherent cells. The ratio is plotted versus the 
percent of adherent cells in the cultures. 
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Adherent and Nonadherent Populations of THP-1 Cells 
~2~I-Plasminogen bound (molecules/cell  x 10  ~) 
Cell population  First adhesion  Second adhesion 
Adherent  0.25  _  0.04  0.28  +  0.06 
Nonadherent  1.22  +  0.25  2.35  +  0.64 
THP-I cells were stimulated with 40 nM PMA.  After  18 h, the adherent and 
nonadherent  cells  from  the  1st  adhesion  were  isolated  and  specific t2~l- 
plasminogen  (at a  100-nM input concentration)  binding  was measured.  The 
nonadherent cells were exposed to a fresh culture flask for 90 min, the adherent 
and  nonadherent  cells  from the  second  adhesion  were  separated,  and  L2Sl- 
plasminogen binding was again measured. The percent of adherent cells in the 
first and second adhesion was 75  and 80%,  respectively.  The results are the 
means  +SD of two  separate  experiments  in which  the  nonstimulated  cells 
bound 0.26  +  0.03  ×  106 plasminogen molecules per cell. 
Upregulation of plasminogen receptors in the nonadherent 
THP-I cells is a rapid phenomenon. In 30 min, the nonadher- 
ent cells bound 3.5-fold more plasminogen than the adherent 
cells (Fig.  5).  Maximal modulation of plasminogen recep- 
tors occurred in 90 min. At this time, 75-90% of cells were 
adherent and an eightfold increase in ~2~I-plasminogen bind- 
ing to the nonadherent population was seen. An initial set of 
experiments was  undertaken  to determine if the adherent 
cells released soluble factors that induced plasminogen bind- 
ing sites in the nonadherent cells.  THP-1 cells were stimu- 
lated with 40 nM PMA in RPMI with or without 10% FCS, 
and  the  conditioned  media derived  after  1.5  or  18  h  was 
added to nonstimulated THP-1 cells grown under conditions 
where  adherence  was  prevented (in polypropylene tubes). 
~25I-plasminogen  binding was measured after culturing  the 
cells in the conditioned media for either  1.5 or 3 h.  These 
cells showed no increase in plasminogen binding relative to 
cells cultured in fresh media with or without FCS. For exam- 
ple, cells cultured for 3 h  in the conditioned FCS or fresh 
media specifically bound  2.8  +  0.2  and 2.4  +  0.3  x  l0  s 
molecules  of  ~25I-plasminogen  per  cell,  respectively  (100 
nM  ~2~I-plasminogen,  60 min incubation at 37°C). 
Finally, we sought to determine whether PMA was unique 
among agonists in modulating plasminogen receptor expres- 
sion (Table V). After 40 h  stimulation of THP-1 cells with 
5 ng/ml vitamin D-3, 55-65 % of the THP-1 cells became ad- 
herent. The nonadherent population bound 1.3  +  0.3  ×  106 
molecules of plasminogen per cell,  whereas adherent cells 
bound  0.3  -1-  0.2  x  l06 molecules of plasminogen  (input 
concentration  100 nM),  a  fourfold difference.  After treat- 
ment of U937 cells with vitamin D-3 under the same condi- 
tions, the nonadherent cells bound 21.7  +  13.6 ×  106 mole- 
cules of plasminogen per cell and adherent cells bound 0.5 
--t- 0.09  ×  106  molecules per cell.  Several  other  agonists 
were also tested, but no modulation of plasminogen binding 
was observed (Table V). These other agonists also failed to 
induce an adherent population of cells. Nevertheless, stimu- 
lation of the cells by the representative agonist, LPS, could 
be documented by increased expression of PCA of the cells. 
Thus, of the agonists tested, only the two that induced adher- 
ence influenced plasminogen receptor expression. 
Functional Consequence of the Modulation of 
Plasminogen Receptors on Monocytoid Cells 
We sought to determine if differences in plasminogen recep- 
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Figure 5. Time course of the upregulation of plasminogen receptors 
in the nonadherent population of THP-I cells. The increase in 12sI- 
plasminogen (Plg) binding to nonadherent THP-1 cells was mea- 
sured as a function of time after stimulation with 40 nM PMA. At 
a  100-nM input concentration  the  number of molecules  of 125I- 
plasminogen specifically bound to the adherent cells at each time 
was assigned a value of 100%,  and the increase in plasminogen 
binding to the nonadherent  cells is calculated  as the percent  in- 
crease  relative to its binding to the adherent cells. 
tor expression were associated with changes in fibrinolytic 
activity of the cells. PMA-stimulated THP-1 cells were sepa- 
rated  into  adherent  and  nonadherent  populations.  These 
cells, as well as nonstimulated cells, were incubated with 15 
/zM plasminogen for 60 min at 37°C, and then the cells were 
washed by centrifugation to remove unbound plasminogen. 
Plasmin generation was measured as a function of time upon 
addition  of u-PA  and  the  plasmin  substrate,  S-2251.  As 
Table V. Effects of  Monocyte Agonists on Plasminogen and 
Urokinase Receptor Expression 
Plasminogen binding  Urokinase binding 
Agonist  (molecules/cell  ×  106)  (molecules/cell  ×  1@) 
None  0.29  2.0 
r-TNFa (200 U/ml)  0.28  2.8 
r-IL-la (5 U/ml)  0.31  ND 
LPS  (10/~g/ml)  0.32  ND 
Vitamin D-3  (5 ng/ml) 
Adherent  0.31  -t-  0.2  0.8  +  0.4 
Nonadherent  1.3  +  0.3  1.2  +  0.7 
Aldosterone (3/zM)  0.38  2.8 
Progesterone (3/~M)  0.38  3.1 
Retinoic  acid  (3/~M)  0.15  4.7 
Testosterone (3/zM)  0.71  2.6 
Progesterone (3 ,uM)  0.40  3.5 
retinoic acid  (3/~M) 
Dexamethasone (3 ,uM)  0.41  3.0 
Dexamethasone (3/~M)  0.47  3.0 
retinoic acid  (3 gM) 
THP-I  cells were stimulated for  18 h with recombinant tumor necrosis factor 
ot (TNF~;  Genzyme  Corp., Boston,  MA),  interleukin  1~ (IL-I~; Genzyme 
Corp.),  lipopolysaccharide  (LPS;  Calbiochem-Behring  Corp.),  vitamin  D-3 
(Hoffmann-La Roche Inc., Montclair,  NJ) or the other indicated agonists (Sig- 
ma Chemical Co.).  The selected concentrations of agonists  were based upon 
those reported to affect monocyte functions (7, 33, 43, 46-48, 50, 62). Only 
vitamin D-3-induced  separatable  adherent  and nonadherent cell populations. 
~25I-plasminogen and ~2~I-urokinase binding was measured with 100 and  1 nM 
input concentrations,  respectively. 
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Figure 6. Plasmin generation by THP-1 cells after PMA stimula- 
tion.  Nonstimulated  (zx) and  the  adherent  (A)  and  nonadherent 
populations (e) of PMA-stimulated cells were incubated with 15 
/zM plasminogen for 1 h at 37°C (in polypropylene tubes to prevent 
adherence). After washing, 3 nM u-PA was added to the system and 
plasmin generation measured as the hydrolysis of the chromogenic 
substrate S-2251 at 405 nm as described in Materials and Methods. 
shown  in  Fig.  6,  the  nonadherent  cells  were  much more 
efficient in generating plasmin activity. After 60 min, eight- 
fold more plasmin activity was generated by the nonadherent 
population  of stimulated  cells  than  by  the  nonstimulated 
cells. The adherent population of cells showed only a twofold 
increase in plasmin-generating activity. 
Modulation of Plasminogen Receptor Expression 
in Monocytes 
Experiments were undertaken to determine whether periph- 
eral blood monocytes could also modulate their expression 
of plasminogen binding sites. In view of the influence of ad- 
herence on plasminogen receptor expression in cells of the 
monocytoid lineage,  blood monocytes were isolated by an 
adherence-independent protocol using centrifugation of blood 
through Sephracell-MN (59). Monocytes were recovered by 
this method at high yield ("~2.8  ×  107 cells from 200 ml of 
peripheral blood cells) and purity (>90%).  The cells were 
cultured for 18 h in the presence or absence of 4 nM PMA 
and then separated into adherent and nonadherent popula- 
tions. Binding isotherms were constructed at 37°C, and the 
Kd and number of plasminogen binding sites derived from 
Scatchard plots are summarized in Table VI. The affinities 
of all populations of monocytes were very similar and consis- 
tent with the value that we have previously reported for mono- 
cytes isolated using  adherence  to fibronectin-gelatin (35). 
The number of plasminogen binding sites was altered by PMA 
stimulation. Both the adherent and the nonadherent popula- 
tions of PMA stimulated cells had significantly (P <  0.02) 
higher plasminogen binding capacities than the nonstimulated 
cells; the extent of the increase was 2.5- to 4.4-fold. Differ- 
ences in plasminogen binding to the adherent and nonadher- 
ent cells were not significantly different (P >  0.5) for either 
the stimulated or nonstimulated cells. When monocytes were 
maintained in suspension for the same time (18 h) in poly- 
propylene tubes, PMA stimulation again induced a similar 
increase in plasminogen binding (Table VI), indicating that 
Table VI. Plasminogen and Urokinase Binding Parameters 
for Peripheral Blood Monocytes 
Plasminogen binding 
Nonstimulated  PMA-stimulated 
Cell 
population  Kd  Sites  Kd  Sites 
ltM  x lO  7  lzM  x  lO  7 
Nonadherent  1.2  +  0.4  1.4  -1-  0.4  1.5  +  0.7  3.5  +  1.3 
Adherent  1.7  +  1.2  1.6  +  0.9  2.2  +  0.6  7.1  +  1.7 
Suspension  2.0  +  1.7  1.7  +  0.4  1.2  +  0.2  4.1  +  0.7 
Urokinase binding (molecules bound per cell  × 104) 
Nonstimulated  PMA-stimulated 
Nonadherent  3.1  +  1.3  2.8  +  1.4 
Adherent  2.6  +  1.5  2.6  +  0.7 
Suspension  2.4  +  0.8  3.2  +  0.9 
Peripheral blood monocytes were isolated by a protocol without an adherence 
step and cultured for 18 h in Mo-Medium (see Materials and Methods), in the 
presence  or absence of 4  nM PMA.  Adherent  and nonadberent  populations 
were separated, At the same time, cells were maintained in suspension for the 
18  h by culturing  in polypropylene  tubes.  Plasminogen binding  parameters 
were determined from specific binding isotherms using the Ligand program. 
]ZSl-urokinase binding was measured using a l-nM input ligand concentration. 
The means  +SD from three experiments are reported. 
a population of adherent cells was not required for the up- 
regulation of receptor expression in the stimulated cells. The 
limited  yield  of monocytes  precluded  detailed  studies  of 
u-PA binding to the same cell populations; however, a suffi- 
cient number of cells were obtained to permit evaluation of 
~25I-u-PA binding at a single ligand dose. At this dose,  1 nM, 
no significant differences in u-PA binding was observed (Ta- 
ble VI). Neither stimulation nor adherence altered the extent 
of u-PA binding. 
The above data indicate that monocytes are similar to the 
monocytoid  cells  with  respect  to  showing  a  selective in- 
crease in plasminogen binding upon  PMA  stimulation.  In 
contrast to the monocytoid cells, however, the expression of 
plasminogen binding sites was not different in the adherent 
and  nonadherent  populations  of stimulated  monocytes.  In 
addition, the monocytes required a longer exposure to PMA 
to alter their plasminogen binding capacity. As noted in Fig. 
5, a marked increase in plasminogen binding to the monocy- 
toid  cells  was  observed  within  30  min  after exposure  to 
PMA. With monocytes, a 6-h exposure to the stimulus was 
required to observe a statistically significant (P < 0.05) differ- 
ence in plasminogen binding to the PMA stimulated versus 
nonstimulated cells (based on six experiments). The values 
for the plasminogen binding capacity of the nonstimulated 
monocytes are 30-80-fold higher than in our previous study 
(35).  In the present study, the monocytes were cultured for 
18 h to allow time for PMA stimulation, whereas previously 
the studies were performed with freshly isolated monocytes. 
Therefore,  a  direct comparison of plasminogen binding to 
fresh  and  cultured  monocytes  was  performed.  The  Kd 
values for the fresh and the cultured monocytes were similar: 
0.9  +  0.1  and  2.0  +  1.7  /~M, respectively (three  experi- 
ments). The number of binding sites in the two preparations 
was  vastly different:  5.0  +  0.1  ×  105  molecules per cell 
with the  fresh monocytes and  1.7  +  0.4  ×  107 molecules 
per cell in the cultured monocytes. Similar increases were 
observed when the monocytes were cultured  in  either the 
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Figure 7. FACS analysis ofplas- 
minogen receptor expression 
on monocytes.  Monocytes  were 
isolated  on  Sephracell-MN 
(59).  Freshly isolated mono- 
cytes (A) or monocytes  cultured 
for 18 h (B) were incubated 
with 100 nM FITC-plasmino- 
gen. The background controls 
in each panel were established 
in  the  presence  of 0.15 M 
6-AHA that blocks plasmino- 
gen binding to its receptors. 
presence or absence of 10% FCS or when monocytes were 
isolated by Ficoll-Hypaque centrifugation and adherence to 
fibronectin-gelatin. An increase was observed as early as 6 
h and remained at a maximally elevated level from 24 to 84 
h. The cultured monocytes were not stimulated on the basis 
of their expression of PCA;  typically, they expressed <30 
mU per 106 cells, similar to the level expressed by the fresh 
monocytes and the level reported for nonstimulated mono- 
cyte preparations (28). In parallel experiments, no difference 
in u-PA binding to the fresh and cultured monocytes was 
noted;  at a  1 nM  ~25I-u-PA input concentration, the fresh 
monocytes bound 2.0  +  0.5  ×  104 molecules per cell com- 
pared to 3.5  +_  1.2  x  104  molecules per cell  (P >  0.5), 
(three experiments) in the cells cultured for 18 h. 
This dramatic  difference in plasminogen binding to the 
fresh  and  cultured  monocytes could also  be  observed by 
FACS analysis. Plasminogen was labeled with FITC and was 
shown to retain its capacity to bind to THP-1 cells. As shown 
in  Fig.  7,  the  fluorescence  associated  with  the  cultured 
monocytes was  1.5-2.0  orders  of magnitude  greater than 
with the same preparation of fresh cells. Addition of 0.15 M 
6-AHA, reduced the fluorescence of both populations to the 
level in the absence of added FITC-plasminogen. The FACS 
analyses further indicate that the entire population of mono- 
cytes, rather than a subpopulation, increased its plasminogen 
binding capacity. 
Discussion 
In response to a variety of agonists, monocytes, and monocy- 
toid cells undergo extensive phenotypic alterations including 
marked changes in their fibrinolytic properties (reviewed in 
reference 11). This study shows that plasminogen receptor 
expression can be dramatically altered in these cells, thus 
demonstrating an additional mechanism for the regulation of 
the  fibrinolytic function of monocytoid cells.  Indeed,  in- 
creased  receptor  expression  was  associated  with  an  en- 
hanced capacity of the cells to generate plasmin, consistent 
with this functional consequence of plasminogen binding to 
cell surfaces (20, 34). Changes in plasminogen receptor ex- 
pression were noted with isolated peripheral blood mono- 
cytes and for the monocytoid cell lines tested although the 
conditions for attaining modulation may not be identical. 
With the monocytoid ceils,  stimulation and an adhesive 
event were both required to elicit the increase in plasmino- 
gen receptor expression. Agonists which stimulate monocy- 
toid cells but do not alter their adhesive properties failed to 
change receptor expression; and, conversely, cell adhesion 
in the absence of a stimulus also failed to induce a change. 
Thus, PMA and vitamin D-3, which induced both adhesion 
and stimulation of monocytoid cells, were unique among the 
agonists tested in enhancing plasminogen receptor expression. 
Other workers have previously reported the modulation of 
u-PA receptors on monocytoid cells by PMA or vitamin D-3 
(14,  29, 44; Lu et al.  1989.  Thromb.  Haemostasis.  61:91). 
Changes in the affinity of u-PA for its receptors on U937 cells 
stimulated with these agonists as well as on the increase in 
the number of u-PA receptors have been noted (14, 44, 52). 
These changes were most pronounced after extended modu- 
lation of the cells with the agonists (4-5 d), suggesting that 
receptor modulation was associated with differentiation of 
the cells to a more macrophage-like phenotype. In our study, 
we were only able to detect modest changes in the number 
of u-PA receptors on the stimulated monocytoid ceils that we 
tested. Differences among U937 cell lines in various labora- 
tories have been reported, including differences in their fi- 
brinolytic functions (32), and these disparities could simply 
reflect differences in the ceils used or in the conditions of  cul- 
ture. From a broader perspective, our data clearly do show 
that plasminogen and u-PA binding sites can be independently 
modulated on ceils. Moreover, as regulation of plasminogen 
receptor expression is a very rapid event, differentiation of 
the monocytoid cells to a more macrophage-like phenotype 
does not appear to be required for these changes to occur. 
The  role of cell  adhesion  in  induction  of plasminogen 
binding sites is complicated. The possibility that adhesion 
prevents the upregulation of plasminogen receptors induced 
by stimulation seems unlikely since the development of a 
population of adherent cells was required to see the increase 
in  plasminogen binding  to  the  nonadherent cells.  As  the 
number of adherent and nonadherent cells was determined 
by  the  available  surface and  the  nonadherent populations 
could rapidly downregulate receptor expression upon adher- 
ence, the differential binding of plasminogen to clonally dis- 
tinct subpopulations of cells can be excluded also. A plausi- 
ble explanation for these observations is that the adherent 
cells  release  components  that  influence the  plasminogen 
binding properties of the nonadherent but not the adherent 
cells.  Proteolysis  of  cells  has  been  recently  shown  to 
markedly augment their ability to bind plasmin (9). The re- 
versibility of plasminogen receptor expression argues against 
a role of released proteases from the adherent cells in the 
process. The communication between the adherent and non- 
adherent cells is rapid and must induce major changes in the 
cell-surface properties to account for the magnitude of the 
increase in receptor number. Cell adhesion is, in fact, known 
to induce rapid changes in the properties of monocytoid cells. 
For example, changes in oncogene expression are initiated 
within 30 min after cell adhesion (23). We have provided ini- 
tial evidence for a role of both proteinaceous and nonprotei- 
naceous (gangliosides) cell surface molecules as plasmino- 
gen binding sites on cells (40). In view of the magnitude of 
the increase in plasminogen binding observed, a major alter- 
ation in the cell-surface properties of the nonadherent cells, 
rather than a change in the density of a single protein recep- 
tor, seems most likely. 
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dramatically  upregulate  their  expression  of  plasminogen 
binding sites  with the monocytoid cell  lines.  As  with the 
monocytoid cells,  PMA stimulation induced an increase in 
plasminogen binding to the monocytes.  In contrast to the 
monocytoid cells,  no difference in plasminogen binding to 
the adherent and nonadherent monocytes was observed. This 
distinction in receptor expression may not represent a genu- 
ine difference  between these  cell  types.  As  culture of the 
monocytes alone caused a marked increase in the number of 
plasminogen binding sites, this change might obscure differ- 
ences among the adherent and the nonadherent populations. 
The changes in receptor expression associated with culture 
of the monocytes do distinguish these cells from the monocy- 
toid cell lines. No difference has been observed in plasmino- 
gen receptor expression by U937 cells or THP-1  cells as a 
function of days in culture (not shown). As the number of 
binding sites on the cultured monocytes approaches that on 
the monocytoid cell lines,  it may  be that the plasminogen 
binding sites on these cell lines are permanently in a partially 
upregulated state. Accordingly, one might speculate as to the 
existence of blood factors that maintain plasminogen recep- 
tors in a downregulated state on circulating monocytes. With 
the increase in plasminogen binding observed with culture 
and with PMA stimulation, monocytes have an intrinsic ca- 
pacity to augment their plasminogen binding by as much as 
300-fold. 
Two new technical procedures have been developed in this 
manuscript that could greatly facilitate analysis of plasmino- 
gen binding  sites.  First,  a  dot-blot analysis  has  been  de- 
scribed that permits detection of plasminogen binding to cell 
extracts.  This protocol permits semiquantitative analysis of 
plasminogen  binding capacities  of cells  and  suggests  that 
plasminogen binding sites can be detergent solubilized,  an 
important initial step for receptor isolation.  Second,  plas- 
minogen binding to cells could be detected by FACS analysis 
using  fluoresceinated  plasminogen.  FACS  analysis  should 
prove particularly useful  for examining the distribution of 
plasminogen binding sites  on different cell  types and sub- 
populations and  for the detection  of abnormal binding of 
plasminogen to cells in pathological circumstances. 
From a biological perspective,  our data suggest that the 
monocyte can upregulate its number of plasminogen recep- 
tors in a very short period of time. Associated with this in- 
crease in receptor number is an increase in the capacity of 
the cells  to generate plasmin.  Plasmin on the cell  surface 
may perform a variety of functions including degradation of 
substratum.  This  would  permit  the  cells  to  migrate  in  a 
directed fashion. After migration, adhesion to a new surface 
would be  associated  with a  rapid downregulation of plas- 
minogen receptor expression, and the cell:substratum con- 
tacts  would become  stabilized.  This  scenario  could be of 
particular importance in inflammatory reactions and for cell 
invasion such as during tumor cell metastasis. 
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